Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-24T18:22:20.742Z Has data issue: false hasContentIssue false
  • English
  • Français

Litigation and the toxicity of psychotropic drugs

Published online by Cambridge University Press:  13 June 2014

Brian E Leonard
Brian E Leonard*
Affiliation:
Pharmacology Department, University College Galway, Galway, Ireland
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

All drugs have side effects and given the increase in litigation for medical negligence that has occurred in Ireland in recent years, it would not be surprising to find that clinicians prescribing psychotropic drugs would also become the target for legal procedures if they fail to warn the patient about the possible side effects and toxicity of the drugs they are prescribing. The two extremes of the problem may be illustrated by the litigation carried out against some pharmaceutical firms and prescribers of benzodiazepines and the lack of such proceedings resulting from deaths of depressed patients who take an overdose of a prescribed antidepressant.

Type
Editorial
Information
Irish Journal of Psychological Medicine , Volume 13 , Issue 3 , September 1996 , pp. 88 - 89
Copyright
Copyright © Cambridge University Press 1996

References

1.Lader, M. Epidemic in the making: benzodiazepine dependence. Tognani, G, Bellantuano, C, Lader, M eds. UB: Epidemiological impact of psychotropic drugs. Amsterdam, North Holland: Elsevier, Biomedical Press, 1981: 99–105.Google Scholar
2.Tyrer, P. Risks of dependence on benzodiazepine drugs: the importance of patient selection. BMJ 1989; 298: 102–5.CrossRefGoogle ScholarPubMed
3.Marks, J. The benzodiazepines: use, misuse, overuse and abuse. Lancaster: MTP Press, 1985.Google Scholar
4.Chaplin, S. Benzodiazepine prescribing. Lancet 1988; 1: 120–2.CrossRefGoogle ScholarPubMed
5.Woods, JH, Katz, JL, Winter, G. Use and abuse of benzodiazepines: issues relevant to prescribing. J Am Med Assoc 1988; 260: 3476–80.CrossRefGoogle ScholarPubMed
6.Cassidy, S, Henry, J. Fatal toxicity of antidepressant drugs in overdose. BMJ 1987; 295: 1021–24.CrossRefGoogle ScholarPubMed
7.Farmer, RDT, Pinder, RM. Why do fatal overdose rates vary between antidepressants? Acta Psychiat Scand 1989; 80 (Suppl 354): 25–35.CrossRefGoogle Scholar
8.Leonard, BE. Tricyclic antidepressants: effective, cheap but are they safe? J Psychopharmac 1996; 10: 35–8.Google Scholar